Morning Overview on MSN
Scientists finally crack mystery of rare blood clots after COVID shots
Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...
IFLScience on MSN
Mystery of rare blood clots after COVID vaccines finally solved after years-long scientific quest
After years of work, scientists have solved the mystery of an unusual side effect that impacted some recipients of the Oxford ...
Scientists say they have identified a mutated autoantibody gene as the mechanism behind rare but serious abnormal blood ...
Yeast-based protein expression systems will play an important role in future health emergencies, according to new analysis, which argues that the approach addresses some of the challenges associated ...
General Electric will launch prefabricated manufacturing units for virus-based gene and cell therapies, vaccines and cancer treatments, the company announced April 17. Here are four things to know. 1.
The vaccine contract manufacturing market offers growth opportunities through increased outsourcing, driven by the need for operational agility and cost efficiency amid rising regulatory challenges.
This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results